Glypican-3: Comparison of a novel stain in immunocytochemistry and immunohistochemistry in hepatocellular carcinoma

被引：0
作者：
Kandil, D.
Leiman, G.
Trotman, W.
Allegretta, M.
Pantanowitz, L.
Goulart, R.
Evans, M.
机构：
[1] Univ Vermont, Burlington, VT USA
[2] Baystate Med Ctr, Springfield, MA USA
来源：
ACTA CYTOLOGICA | 2007年 / 51卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：331 / 331
页数：1
相关论文
共 50 条
[41]   Glypican-3 expression is correlated with poor prognosis in hepatocellular carcinoma [J].
Shirakawa, Hirofumi ;
Suzuki, Hitomi ;
Shimomura, Manami ;
Kojima, Motohiro ;
Gotohda, Naoto ;
Takahashi, Shinichiro ;
Nakagohri, Toshio ;
Konishi, Masaru ;
Kobayashi, Nobuaki ;
Kinoshita, Taira ;
Nakatsura, Tetsuya .
CANCER SCIENCE, 2009, 100 (08) :1403-1407
[42]   ImmunoPET as Stoichiometric Sensor for Glypican-3 in Models of Hepatocellular Carcinoma [J].
Kelada, O. J. ;
Gutsche, N. T. ;
Bell, M. ;
Berman, R. M. ;
Baidoo, K. E. ;
Warner, B. M. ;
Szajek, L. P. ;
Hong, J. ;
Ho, M. ;
Choyke, P. ;
Escorcia, F. E. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03) :S180-S181
[43]   Progress and challenges in glypican-3 targeting for hepatocellular carcinoma therapy [J].
Couzinet, Arnaud ;
Suzuki, Toshihiro ;
Nakatsura, Tetsuya .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2024, 28 (10) :895-909
[44]   Glypican-3: A New Target for Diagnosis and Treatment of Hepatocellular Carcinoma [J].
Guo, Meng ;
Zhang, Hailing ;
Zheng, Jianming ;
Liu, Yangfang .
JOURNAL OF CANCER, 2020, 11 (08) :2008-2021
[45]   Evaluation of the Glypican-3 Promoter for Transcriptional Targeting of Hepatocellular Carcinoma [J].
Dhungel, Bijay ;
Jayachandran, Aparna ;
Shrestha, Ritu ;
Ramlogan-Steel, Charmaine ;
Layton, Christopher J. ;
Steel, Jason C. .
MOLECULAR THERAPY, 2017, 25 (05) :68-68
[46]   Identification of nanobodies against hepatocellular carcinoma marker glypican-3 [J].
Wang, Wenyi ;
Xu, Chang ;
Wang, Huanan ;
Jiang, Changan .
MOLECULAR IMMUNOLOGY, 2021, 131 :13-22
[47]   Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma [J].
Yukihiro Haruyama ;
Hiroaki Kataoka .
World Journal of Gastroenterology, 2016, (01) :275-283
[48]   The Effect of the Etiology of Cirrhosis on Glypican-3 Expression in Hepatocellular Carcinoma [J].
Orrock, J. M. ;
Mounajjed, T. ;
Zhang, L. ;
Wu, T-T .
LABORATORY INVESTIGATION, 2012, 92 :421A-421A
[49]   The Effect of the Etiology of Cirrhosis on Glypican-3 Expression in Hepatocellular Carcinoma [J].
Orrock, J. M. ;
Mounajjed, T. ;
Zhang, L. ;
Wu, T-T .
MODERN PATHOLOGY, 2012, 25 :421A-421A
[50]   Glypican-3 immunocytochemistry in liver fine-needle aspirates - A novel stain to assist in the differentiation of benign and malignant liver lesions [J].
Kandil, Dina ;
Leiman, Gladwyn ;
Allegretta, Mark ;
Trotman, Winifred ;
Pantanowitz, Liron ;
Goulart, Robert ;
Evans, Mark .
CANCER CYTOPATHOLOGY, 2007, 111 (05) :316-322
12345